Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Host-pathogen interactions in Campylobacter infections: the host perspective.

Janssen R, Krogfelt KA, Cawthraw SA, van Pelt W, Wagenaar JA, Owen RJ.

Clin Microbiol Rev. 2008 Jul;21(3):505-18. doi: 10.1128/CMR.00055-07. Review.

2.

Delineation of the innate and adaptive T-cell immune outcome in the human host in response to Campylobacter jejuni infection.

Edwards LA, Nistala K, Mills DC, Stephenson HN, Zilbauer M, Wren BW, Dorrell N, Lindley KJ, Wedderburn LR, Bajaj-Elliott M.

PLoS One. 2010 Nov 9;5(11):e15398. doi: 10.1371/journal.pone.0015398.

3.

Vaccines against Campylobacter jejuni.

Scott DA.

J Infect Dis. 1997 Dec;176 Suppl 2:S183-8. Review.

PMID:
9396708
4.

Murine infection models for the investigation of Campylobacter jejuni--host interactions and pathogenicity.

Heimesaat MM, Bereswill S.

Berl Munch Tierarztl Wochenschr. 2015 Mar-Apr;128(3-4):98-103.

PMID:
25876268
5.

Assessment of the duration of protection in Campylobacter jejuni experimental infection in humans.

Tribble DR, Baqar S, Scott DA, Oplinger ML, Trespalacios F, Rollins D, Walker RI, Clements JD, Walz S, Gibbs P, Burg EF 3rd, Moran AP, Applebee L, Bourgeois AL.

Infect Immun. 2010 Apr;78(4):1750-9. doi: 10.1128/IAI.01021-09. Epub 2010 Jan 19.

6.

Glycoconjugates play a key role in Campylobacter jejuni Infection: interactions between host and pathogen.

Day CJ, Semchenko EA, Korolik V.

Front Cell Infect Microbiol. 2012 Feb 14;2:9. doi: 10.3389/fcimb.2012.00009. eCollection 2012. Review.

7.

The immunobiology of Campylobacter jejuni: Innate immunity and autoimmune diseases.

Phongsisay V.

Immunobiology. 2016 Apr;221(4):535-43. doi: 10.1016/j.imbio.2015.12.005. Epub 2015 Dec 8. Review.

PMID:
26709064
8.

Oral immunization with cholera toxin provides protection against Campylobacter jejuni in an adult mouse intestinal colonization model.

Albert MJ, Mustafa AS, Islam A, Haridas S.

MBio. 2013 May 7;4(3):e00246-13. doi: 10.1128/mBio.00246-13.

9.

Campylobacter jejuni strain CG8421: a refined model for the study of Campylobacteriosis and evaluation of Campylobacter vaccines in human subjects.

Tribble DR, Baqar S, Carmolli MP, Porter C, Pierce KK, Sadigh K, Guerry P, Larsson CJ, Rockabrand D, Ventone CH, Poly F, Lyon CE, Dakdouk S, Fingar A, Gilliland T, Daunais P, Jones E, Rymarchyk S, Huston C, Darsley M, Kirkpatrick BD.

Clin Infect Dis. 2009 Nov 15;49(10):1512-9. doi: 10.1086/644622.

PMID:
19842970
10.

Intestinal microbiota shifts towards elevated commensal Escherichia coli loads abrogate colonization resistance against Campylobacter jejuni in mice.

Haag LM, Fischer A, Otto B, Plickert R, Kühl AA, Göbel UB, Bereswill S, Heimesaat MM.

PLoS One. 2012;7(5):e35988. doi: 10.1371/journal.pone.0035988. Epub 2012 May 1.

11.

New World monkey Aotus nancymae as a model for Campylobacter jejuni infection and immunity.

Jones FR, Baqar S, Gozalo A, Nunez G, Espinoza N, Reyes SM, Salazar M, Meza R, Porter CK, Walz SE.

Infect Immun. 2006 Jan;74(1):790-3.

12.

The second century of Campylobacter research: recent advances, new opportunities and old problems.

Dorrell N, Wren BW.

Curr Opin Infect Dis. 2007 Oct;20(5):514-8. Review.

PMID:
17762786
13.

Molecular mechanisms of campylobacter infection.

van Putten JP, van Alphen LB, Wösten MM, de Zoete MR.

Curr Top Microbiol Immunol. 2009;337:197-229. doi: 10.1007/978-3-642-01846-6_7. Review.

PMID:
19812984
14.

[Evaluation of immunological efficiency induced by Campylobacter jejuni PEB1 DNA combined with PEB1 protein in mice].

Liu L, Lai W, Hu N, Zhang W, Chen T, Wang F, Gu R.

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2014 Jun;30(6):576-80. Chinese.

PMID:
24909276
15.

Recombinant PorA, the major outer membrane protein of Campylobacter jejuni, provides heterologous protection in an adult mouse intestinal colonization model.

Islam A, Raghupathy R, Albert MJ.

Clin Vaccine Immunol. 2010 Nov;17(11):1666-71. doi: 10.1128/CVI.00255-10. Epub 2010 Sep 22.

16.

Genetic background of IL-10(-/-) mice alters host-pathogen interactions with Campylobacter jejuni and influences disease phenotype.

Mansfield LS, Patterson JS, Fierro BR, Murphy AJ, Rathinam VA, Kopper JJ, Barbu NI, Onifade TJ, Bell JA.

Microb Pathog. 2008 Oct;45(4):241-57. doi: 10.1016/j.micpath.2008.05.010. Epub 2008 Jun 11.

17.

Campylobacter jejuni-mediated disease pathogenesis: an update.

Zilbauer M, Dorrell N, Wren BW, Bajaj-Elliott M.

Trans R Soc Trop Med Hyg. 2008 Feb;102(2):123-9. Epub 2007 Nov 19. Review.

PMID:
18023831
18.

Update on human Campylobacter jejuni infections.

Kirkpatrick BD, Tribble DR.

Curr Opin Gastroenterol. 2011 Jan;27(1):1-7. doi: 10.1097/MOG.0b013e3283413763. Review.

PMID:
21124212
19.

A capsule conjugate vaccine approach to prevent diarrheal disease caused by Campylobacter jejuni.

Maue AC, Poly F, Guerry P.

Hum Vaccin Immunother. 2014;10(6):1499-504. doi: 10.4161/hv.27985. Epub 2014 Mar 14. Review.

20.

Campylobacter jejuni in broiler chickens: colonization and humoral immunity following oral vaccination and experimental infection.

Rice BE, Rollins DM, Mallinson ET, Carr L, Joseph SW.

Vaccine. 1997 Dec;15(17-18):1922-32.

PMID:
9413103

Supplemental Content

Support Center